CohBar Inc
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fi… Read more
Market Cap & Net Worth: CohBar Inc (CWBR)
CohBar Inc (NASDAQ:CWBR) has a market capitalization of $1.57 Million ($1.57 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #35365 globally and #11526 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CohBar Inc's stock price $0.54 by its total outstanding shares 2906930 (2.91 Million).
CohBar Inc Market Cap History: 2015 to 2024
CohBar Inc's market capitalization history from 2015 to 2024. Data shows change from $96.80 Million to $1.57 Million (-37.32% CAGR).
CohBar Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CohBar Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CWBR by Market Capitalization
Companies near CohBar Inc in the global market cap rankings as of March 19, 2026.
Key companies related to CohBar Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CohBar Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, CohBar Inc's market cap moved from $96.80 Million to $ 1.57 Million, with a yearly change of -37.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $1.57 Million | -26.96% |
| 2023 | $2.15 Million | -56.34% |
| 2022 | $4.93 Million | -83.85% |
| 2021 | $30.51 Million | -73.89% |
| 2020 | $116.86 Million | -16.25% |
| 2019 | $139.53 Million | -48.55% |
| 2018 | $271.22 Million | -37.42% |
| 2017 | $433.42 Million | +142.44% |
| 2016 | $178.78 Million | +84.68% |
| 2015 | $96.80 Million | -- |
End of Day Market Cap According to Different Sources
On Dec 22nd, 2025 the market cap of CohBar Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.57 Million USD |
| MoneyControl | $1.57 Million USD |
| MarketWatch | $1.57 Million USD |
| marketcap.company | $1.57 Million USD |
| Reuters | $1.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.